This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, P.-C. Articles by Lipkin, S. M. Search for Related Content PubMed PubMed Citation Articles by Chen, P.-C. Articles by Lipkin, S. M.

Contributions by MutL Homologues Mlh3 and Pms2 to DNA Mismatch Repair and Tumor Suppression in the Mouse

¹ Department of Medicine and Biological Chemistry, University of California, Irvine, Irvine, California; ² Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon; ³ Molecular and Computational Biology, University of Southern California, Los Angeles, California; and ⁴ Strang Cancer Research Laboratory at the Rockefeller University, New York, New York

Requests for reprints: Steven M. Lipkin, Cancer Genetics Clinic, Chao Family National Cancer Institute Designated Comprehensive Cancer Center, University of California, Irvine, 204 Sprague Hall ZC 4038, Irvine, CA 92697-4038. Phone: 949-824-9219; Fax: 949-824-9224; E-mail: slipkin{at}uci.edu.

Germ line DNA mismatch repair mutations in MLH1 and MSH2 underlie the vast majority of hereditary non-polyposis colon cancer. Four mammalian homologues of Escherichia coli MutL heterodimerize to form three distinct complexes: MLH1/PMS2, MLH1/MLH3, and MLH1/PMS1. Although MLH1/PMS2 is generally thought to have the major MutL activity, the precise contributions of each MutL heterodimer to mismatch repair functions are poorly understood. Here, we show that Mlh3 contributes to mechanisms of tumor suppression in the mouse. Mlh3 deficiency alone causes microsatellite instability, impaired DNA-damage response, and increased gastrointestinal tumor susceptibility. Furthermore, Mlh3;Pms2 double-deficient mice have tumor susceptibility, shorter life span, microsatellite instability, and DNA-damage response phenotypes that are indistinguishable from Mlh1-deficient mice. Our data support previous results from budding yeast that show partial functional redundancy between MLH3 and PMS2 orthologues for mutation avoidance and show a role for Mlh3 in gastrointestinal and extragastrointestinal tumor suppression. The data also suggest a mechanistic basis for the more severe mismatch repair–related phenotypes and cancer susceptibility in Mlh1- versus Mlh3- or Pms2-deficient mice. Contributions by both MLH1/MLH3 and MLH1/PMS2 complexes to mechanisms of mismatch repair–mediated tumor suppression, therefore, provide an explanation why, among MutL homologues, only germ line mutations in MLH1 are common in hereditary non-polyposis colon cancer.

This article has been cited by other articles:

				R. A. Edwards, M. Witherspoon, K. Wang, K. Afrasiabi, T. Pham, L. Birnbaumer, and S. M. Lipkin Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease-Associated Colorectal Cancer Cancer Res., August 15, 2009; 69(16): 6423 - 6429. [Abstract] [Full Text] [PDF]

				S. N. Shah and K. A. Eckert Human Postmeiotic Segregation 2 Exhibits Biased Repair at Tetranucleotide Microsatellite Sequences Cancer Res., February 1, 2009; 69(3): 1143 - 1149. [Abstract] [Full Text] [PDF]

				H. Feitsma, R. V. Kuiper, J. Korving, I. J. Nijman, and E. Cuppen Zebrafish with Mutations in Mismatch Repair Genes Develop Neurofibromas and Other Tumors Cancer Res., July 1, 2008; 68(13): 5059 - 5066. [Abstract] [Full Text] [PDF]

				J. M. Harrington and R. D. Kolodner Saccharomyces cerevisiae Msh2-Msh3 Acts in Repair of Base-Base Mispairs Mol. Cell. Biol., September 15, 2007; 27(18): 6546 - 6554. [Abstract] [Full Text] [PDF]

				E. Cannavo, B. Gerrits, G. Marra, R. Schlapbach, and J. Jiricny Characterization of the Interactome of the Human MutL Homologues MLH1, PMS1, and PMS2 J. Biol. Chem., February 2, 2007; 282(5): 2976 - 2986. [Abstract] [Full Text] [PDF]

				G. Plotz, C. Welsch, L. Giron-Monzon, P. Friedhoff, M. Albrecht, A. Piiper, R. M. Biondi, T. Lengauer, S. Zeuzem, and J. Raedle Mutations in the MutS{alpha} interaction interface of MLH1 can abolish DNA mismatch repair Nucleic Acids Res., December 2, 2006; 34(22): 6574 - 6586. [Abstract] [Full Text] [PDF]

				D. C. Hegan, L. Narayanan, F. R. Jirik, W. Edelmann, R.M. Liskay, and P. M. Glazer Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6 Carcinogenesis, December 1, 2006; 27(12): 2402 - 2408. [Abstract] [Full Text] [PDF]

				N. P. Taylor, M. A. Powell, R. K. Gibb, J. S. Rader, P. C. Huettner, S. N. Thibodeau, D. G. Mutch, and P. J. Goodfellow MLH3 Mutation in Endometrial Cancer. Cancer Res., August 1, 2006; 66(15): 7502 - 7508. [Abstract] [Full Text] [PDF]

				X. Wu, C. Y. Tsai, M. B. Patam, H. Zan, J. P. Chen, S. M. Lipkin, and P. Casali A Role for the MutL Mismatch Repair Mlh3 Protein in Immunoglobulin Class Switch DNA Recombination and Somatic Hypermutation J. Immunol., May 1, 2006; 176(9): 5426 - 5437. [Abstract] [Full Text] [PDF]

				E. C. Chao and S. M. Lipkin Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis Nucleic Acids Res., February 6, 2006; 34(3): 840 - 852. [Abstract] [Full Text] [PDF]

				E. Cannavo, G. Marra, J. Sabates-Bellver, M. Menigatti, S. M. Lipkin, F. Fischer, P. Cejka, and J. Jiricny Expression of the MutL Homologue hMLH3 in Human Cells and its Role in DNA Mismatch Repair Cancer Res., December 1, 2005; 65(23): 10759 - 10766. [Abstract] [Full Text] [PDF]